25.39
0.00
(0.00%)
At close: 6:52:46 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 7 | 15 | 17 |
| Avg. Estimate | 2.88B | 2.81B | 11.71B | 11.94B |
| Low Estimate | 2.88B | 2.81B | 11.71B | 11.86B |
| High Estimate | 2.89B | 2.82B | 11.75B | 12.13B |
| Year Ago Sales | 2.91B | 2.79B | 12.05B | 11.71B |
| Sales Growth (year/est) | -0.85% | 0.53% | -2.81% | 1.93% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0I2P.L | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 4/7/2025 |
| Initiated | Morgan Stanley: Equal-Weight | 3/24/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 3/6/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 2/25/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 2/24/2025 |
| Maintains | Stifel: Hold to Hold | 2/19/2025 |